Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185744 · ClinicalTrials.gov registry record · NA
Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer
A NA study of Breast Cancer and Carcinoma, Ductal, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 121
- Enrollment target
- 1
- Study location
NCT00185744: Active NA study of Breast Cancer and Carcinoma, Ductal, sponsored by Stanford University.
NCT00185744 is a NA study of Breast Cancer and Carcinoma, Ductal that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 121 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185744, a NA study of Breast Cancer and Carcinoma, Ductal, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine whether an accelerated course of radiotherapy delivered to the lumpectomy cavity plus margin using IORT as a single dose, intracavitary brachytherapy with the MammoSite device over 5 days, partial breast 3-D CRT in 5 days, or stereotactic APBI over 4 days is a feasible and safe alternative to a six and a half week course of whole breast radiotherapy. The study will measure both short and long-term complications of radiation treatment, short and long-term breast cosmesis, local rates of in-breast cancer recurrence, regional recurrences, distant metastases, and overall survival.
Primary Outcome
Proportion of subjects that experience in-breast tumor recurrence (IBTR), to be assessed through or by March 2029
Conditions Studied
Interventions
- PROCEDURE Lumpectomy
- RADIATION Intra-Operative Radiotherapy (IORT)
- RADIATION Whole Breast Radiotherapy
- RADIATION Intracavitary Brachytherapy
- RADIATION Accelerated External Beam 3-D Conformal Radiotherapy
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2002-09 |
| Est. Completion | 2029-03 |
| Phase | NA |
What the registry record for NCT00185744 still lists
NCT00185744 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which Lumpectomy is the first listed.
NCT00185744 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00185744 about?
NCT00185744 is a clinical study titled "Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer". To determine whether an accelerated course of radiotherapy delivered to the lumpectomy cavity plus margin using IORT as a single dose, intracavitary brachytherapy with the MammoSite device over 5 days, partial breast 3-D CRT in 5 days, or stereotactic APBI over 4 days is a feasible and safe alternat...
What is the current status of trial NCT00185744?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 121 participants. The study started on 2002-09. Estimated completion is 2029-03.
What conditions does trial NCT00185744 study?
This clinical trial studies the following conditions: Breast Cancer, Carcinoma, Ductal.
What interventions are being tested in trial NCT00185744?
The interventions under investigation include: Lumpectomy (PROCEDURE), Intra-Operative Radiotherapy (IORT) (RADIATION), Whole Breast Radiotherapy (RADIATION), Intracavitary Brachytherapy (RADIATION), Accelerated External Beam 3-D Conformal Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT00185744?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00185744 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00185744's enrollment target sits among peer trials
121 506th of 1224 higher than 716 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia